Drug Type Monoclonal antibody |
Synonyms- |
Target |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization GLPG US, Inc.StartupXi'an Yufan Biotechnologies Co., Ltd.Startup |
Active Organization Xi'an Yufan Biotechnologies Co., Ltd.StartupGLPG US, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lymphoproliferative Disorders | Discovery | - | GLPG US, Inc.Startup | 22 Dec 2022 |
Lymphoproliferative Disorders | Discovery | - | 22 Dec 2022 | |
Neoplasms | Discovery | - | 22 Dec 2022 | |
Neoplasms | Discovery | - | GLPG US, Inc.Startup | 22 Dec 2022 |